Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/30/2788530/0/en/Ocuphire-Pharma-Announces-Presentation-at-Ophthalmology-Innovation-Summit-OIS-XIII.html

FARMINGTON HILLS, Mich., Nov. 30, 2023 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced that the Company’s CEO, George Magrath M.D., M.B.A., M.S., will deliver a presentation at the Ophthalmology Innovation Summit (OIS XIII), to take place in San Diego, CA on December 1-2, 2023.

Read more at globenewswire.com

Related news for (OCUP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.